รายละเอียด

-- Patient-centered approach in type 2 diabetes management
-- LDL cholesterol target : How low should we go?
-- New era of non-statin therapies : ezetimibe, PCSK9 inhibitors, bempedoic acid or else
-- Aspirin for primary prevention : What is the future direction?
-- Optimal blood pressure target in hypertension and how to reach
-- How to deal with resistant hypertension?
-- Coronary artery calcium score for CV risk stratification
-- Revascularization in ischemic cardiomyopathy : Hope or hype?
-- Non-invasive assessment of ischemia in chronic coronary syndrome : Do we still need it?
-- Influenza vaccine after acute coronary syndrome -- Early rule-out pathway for acute myocardial infarction
-- SAVR or TAVR?
-- Simple congenital defects : Are they really simple?
-- Dealing with cyanotic heart disease sequelae : What and how?
-- Decongestion in acute heart failure -- Cardio-oncology : Is troponin the most valuable player in doxorubicin-induced cardiotoxicity?
-- ATTR amyloidosis in the spotlight
-- Dilated cardiomyopathy : The dawn of cardiogenetics -- Is CHA2DS2-VASc score valid in Asian population?
-- Any options for AF thrombo-prophylaxis in very high bleeding risk patients?
-- How to deal with patients with PVCs?
-- Rate versus rhythm control in AF : Who is the winner?
-- Pharmacological treatment in pulmonary arterial hypertension
-- What should we know about chronic thrombo-embolic pulmonary disease?
-- Preoperative cardiovascular evaluation in non-cardiac surgery
-- Extracorporeal CPR for out-of-hospital cardiac arrest
-- Cannabis and cardiovascular effects : The good and the bad
-- Air pollution and cardiovascular disease : Particulate matter matters
-- Supplements for cardiovascular disease : What is safe and what is not?